These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32702703)

  • 1. Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis.
    Schamroth Pravda M; Cohen Hagai K; Topaz G; Schamroth Pravda N; Makhoul N; Shuvy M; Benchetrit S; Assali A; Pereg D
    Am J Nephrol; 2020; 51(8):635-640. PubMed ID: 32702703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients.
    Okubo A; Doi T; Morii K; Nishizawa Y; Yamashita K; Shigemoto K; Mizuiri S; Usui K; Arita M; Naito T; Masaki T
    Am J Nephrol; 2022; 53(2-3):169-175. PubMed ID: 35259747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
    Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
    Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHA2DS2-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients.
    Vodošek Hojs N; Ekart R; Bevc S; Piko N; Hojs R
    Am J Nephrol; 2021; 52(5):404-411. PubMed ID: 33975308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome.
    Rozenbaum Z; Elis A; Shuvy M; Vorobeichik D; Shlomo N; Shlezinger M; Goldenberg I; Kimhi O; Pereg D
    Eur J Intern Med; 2016 Dec; 36():57-61. PubMed ID: 27707608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining CHA
    Chu SY; Li PW; Fan FF; Han XN; Liu L; Wang J; Zhao J; Ye XJ; Ding WH
    BMC Anesthesiol; 2021 Nov; 21(1):276. PubMed ID: 34753422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification Using the CHA
    Parodi G; Scudiero F; Citro R; Silverio A; Bellandi B; Zito C; Antonini-Canterin F; Rigo F; Zocchi C; Bossone E; Salerno-Uriarte J; Piscione F; Mario CD;
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28912212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting stroke and death in patients with heart failure using CHA
    Son MK; Lim NK; Park HY
    BMC Cardiovasc Disord; 2019 Aug; 19(1):193. PubMed ID: 31395009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of CHA2DS2-VASc score for predicting cardiovascular and cerebrovascular outcomes in acute myocardial infarction patients.
    Li CY; Chang CJ; Chung WJ; Lin CJ; Hsueh SK; Lee CH; Wu CJ; Tsai TH; Cheng CI
    Medicine (Baltimore); 2018 Jul; 97(28):e11230. PubMed ID: 29995755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the CHA
    Orvin K; Levi A; Landes U; Bental T; Sagie A; Shapira Y; Vaknin-Assa H; Assali A; Kornowski R
    Am J Cardiol; 2018 Jan; 121(2):241-248. PubMed ID: 29157734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the CHA2DS2-VASC Score to Predict Adverse Outcomes in Patients Having Percutaneous Coronary Intervention.
    Orvin K; Bental T; Assali A; Lev EI; Vaknin-Assa H; Kornowski R
    Am J Cardiol; 2016 May; 117(9):1433-8. PubMed ID: 27001448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K antagonist use and mortality in dialysis patients.
    Voskamp PWM; Rookmaaker MB; Verhaar MC; Dekker FW; Ocak G
    Nephrol Dial Transplant; 2018 Jan; 33(1):170-176. PubMed ID: 28992189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Risk Scoring System to Predict Cardiovascular Death in Patients With Acute Myocardial Infarction: CHA
    Kundi H; Kiziltunc E; Korkmaz A; Cicek G; Ornek E; Ileri M
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):273-278. PubMed ID: 28627231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke and death prediction with CHA2DS2-vasc score after myocardial infarction in patients without atrial fibrillation.
    Podolecki T; Lenarczyk R; Kowalczyk J; Swierad M; Swiatkowski A; Jedrzejczyk E; Chodor P; Zielinska T; Kalarus Z
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):497-502. PubMed ID: 25829193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The predictive value of the CHA
    Qing P; Yang YM; Hu LT; Yu W; Xu LL; Wang N; Suo N
    Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):177-184. PubMed ID: 35090253
    [No Abstract]   [Full Text] [Related]  

  • 20. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.